PledPharma develops new drugs that protect the body against oxidative stress – a potentially debilitating and sometimes life-threatening condition that can be caused by chemotherapy treatment and following acetaminophen (paracetamol) overdose. The company's most advanced project PledOx® reduces nerve damage associated with chemotherapy. A phase IIb study has been conducted and will serve as the basis for the continued phase III development. The drug candidate Aladote® is being developed to reduce the risk of acute liver failure associated with acetaminophen poisoning. PledPharma (STO: PLED) is listed on Nasdaq First North
| Website | http://www.pledpharma.se |
| Ticker | STO:PLED |
| Revenue | $5 million |
| Employees | 1 (0 on RocketReach) |
| Founded | 2006 |
| Address | Grev Turegatan 11 C, Stockholm, Stockholm 114 46, SE |
| Phone | +1 468-679-7210 |
| Fax | (468) 663-5725 |
| Technologies | |
| Industry | Biotechnology, Pharmaceutical Manufacturing, Drug Manufacturing & Research, Drug Discovery, Pharmaceuticals, Science and Engineering, Healthcare, Pharmaceutical, Health Care |
| Web Rank | 11 Million |
| Keywords | Drug Development, New Drug Therapies, Pharmaceutical Research, Medical Research, Novel Therapeutics, Drug Discovery, Clinical Trials, Antioxidant Therapy, Free Radical Damage, Toxicology Research |
| Competitors | Roche, Novartis, Merck AH, Pfizer, Sanofi, AstraZeneca, Novo Nordisk, Bristol Myers Squibb, Gilead Sciences, Lilly India +42 more (view full list) |
| SIC | SIC Code 62 Companies, SIC Code 628 Companies |
| NAICS | NAICS Code 523 Companies, NAICS Code 523920 Companies, NAICS Code 52392 Companies, NAICS Code 52 Companies, NAICS Code 5239 Companies |
Looking for a particular PledPharma AB employee's phone or email?
PledPharma AB Questions
The PledPharma AB annual revenue was $5 million in 2026.
PledPharma AB is based in Stockholm, Stockholm.
The NAICS codes for PledPharma AB are [523, 523920, 52392, 52, 5239].
The SIC codes for PledPharma AB are [62, 628].
Related Companies
